| Mylan Pharma GmbH - Pantoprazol Viatris 20 mg, magensaftresistente Tablette | | 68642 | | 01 | | Pantoprazol Viatris 20 mg | | magensaftresistente Tablette | | A02BC02 | | Pantoprazol | | 10.12.2021 | | |
| | Composition | | pantoprazolum 20 mg ut pantoprazolum natricum sesquihydricum, trinatrii phosphas anhydricus, isomaltum 29.25 mg, carmellosum natricum, crospovidonum, natrii stearylis fumaras, Überzug: hypromellosum, povidonum K 25, propylenglycolum, E 171, E 172 (flavum), acidi methacrylici et ethylis acrylatis polymerisatum 1:1, triethylis citras, dimeticonum, sorbitani stearas, polysorbatum 60, silica colloidalis anhydrica, xanthani gummi, E 210 <0.65 µg, E 200, kalii hydroxidum, acidum hydrochloridum, pro compresso obducto corresp. natrium 3.58 mg. | | Packungsbestandteile | | Comprimés résistants au suc gastrique | | | | | Principe actif | Concentr. |
|---|
| Pantoprazole | 20 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Pantoprazole | 20 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | Acidi Methacrylici | | | | Acidum Hydrochloridum | | | | Carmellose Sodique | | | | Crospovidonum | | | | Dimeticone | | | | E 171 | | color. | | E 172 | | color. | | E 200 | | conserv. | | Ethylis Acrylatis Polymerisatum | | | | Hypromellosum | | Überzug | | Isomaltum | 29.25 mg | | | Kalii Hydroxidum | | | | Natrii Stearylis Fumaras | | | | Polysorbatum 60 | | | | Povidonum K | 25 | | | Pro Compresso Obducto | | | | Propylenglycol | | | | Silica Colloidalis Anhydrica | | | | Sorbitani Stearas | | | | Triethylis Citras | | | | Trinatrii Phosphas Anhydricus | | | | Xanthani Gummi | | |
| |
| |
|
